Quality Control Process for EQ-5D-5L Valuation Studies

被引:124
|
作者
Ramos-Goni, Juan M. [1 ]
Oppe, Mark [1 ]
Slaap, Bernhard [1 ]
Busschbach, Jan J. V. [2 ]
Stolk, Elly [1 ,3 ]
机构
[1] EuroQol Res Fdn, Execut Off, Marten Meesweg 107, NL-3068 AV Rotterdam, Netherlands
[2] Erasmus MC, Dept Psychiat, Sect Med Psychol, Rotterdam, Netherlands
[3] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands
关键词
economic; health status index; life valuation; quality control; quality of life; CLINICAL-TRIALS; TTO;
D O I
10.1016/j.jval.2016.10.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: The values of the five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) are elicited using composite time trade-off and discrete choice experiments. Unfortunately, data quality issues and interviewer effects were observed in the first few EQ-5D-5L valuation studies. To prevent these issues from occurring in later studies, the EuroQol Group established a cyclic quality control (QC) process. Objectives: To describe this QC process and show its impact on data quality. Methods: A newly developed QC tool provided information about protocol compliance, interviewer effects, and mean values by health state severity. In a cyclic process, this information is initially used to evaluate whether new interviewers meet minimal quality requirements and later to provide feedback about how their performance may be improved. To investigate the impact of this cyclic process, we compared the quality of the data in Dutch and Spanish valuation studies that did not have this QC process with that in the follow-up studies in the same countries that used the QC process. Data quality was measured using protocol violations, variability between interviewers, the proportion of inconsistent responders, and clustering of composite time trade-off values. Results: In Spain, protocol violations were reduced from 87% in the valuation study to 5% in the followup study and in the Netherlands from 20% to 8%. In both countries, interviewers performed more homogeneously in the follow-up studies. The number of inconsistent respondents was reduced by 23.2% in Spain and 23.6% in the Netherlands. Values were less clustered in the follow-up studies. Conclusions: The implementation of a strict QC process in EQ-5D-5L valuation studies increases interviewer protocol compliance and promotes data quality.
引用
收藏
页码:466 / 473
页数:8
相关论文
共 50 条
  • [1] Quality control of the data on the Portuguese study for the valuation of the EQ-5D-5L
    Antunes, Patricia
    Ferreira, Pedro Lopes
    Ferreira, Lara Noronha
    Pereira, Luis
    [J]. QUALITY OF LIFE RESEARCH, 2018, 27 : S62 - S62
  • [2] Valuation of the EQ-5D-5L in Taiwan
    Lin, Hsiang-Wen
    Li, Chia-Ing
    Lin, Fang-Ju
    Chang, Jen-Yu
    Gau, Churn-Shiouh
    Luo, Nan
    Pickard, A. Simon
    Goni, Juan M. Ramos
    Tang, Chao-Hsiun
    Hsu, Chien-Ning
    [J]. PLOS ONE, 2018, 13 (12):
  • [3] Toward a Smaller Design for EQ-5D-5L Valuation Studies
    Yang, Zhihao
    Luo, Nan
    Oppe, Mark
    Bonsel, Gouke
    Busschbach, Jan
    Stolk, Elly
    [J]. VALUE IN HEALTH, 2019, 22 (11) : 1295 - 1302
  • [4] EQ-5D-5L valuation study for Portugal
    Ferreira, Pedro L.
    Antunes, Patricia
    Ferreira, Lara N.
    Pereira, Luis N.
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87
  • [5] The EQ-5D-5L valuation study in Korea
    Seon-Ha Kim
    Jeonghoon Ahn
    Minsu Ock
    Sangjin Shin
    Jooyeon Park
    Nan Luo
    Min-Woo Jo
    [J]. Quality of Life Research, 2016, 25 : 1845 - 1852
  • [6] EQ-5D-5L Valuation for the Malaysian Population
    Shafie, Asrul Akmal
    Thakumar, Annushiah Vasan
    Lim, Ching Jou
    Luo, Nan
    Rand-Hendriksen, Kim
    Yusof, Faridah Aryani Md
    [J]. PHARMACOECONOMICS, 2019, 37 (05) : 715 - 725
  • [7] EQ-5D-5L VALUATION STUDY IN TAIWAN
    Lin, H.
    Li, C.
    Lin, F.
    Chang, J.
    Gau, C.
    Luo, N.
    Pickard, A. S.
    Goni, Ramos J. M.
    Tang, C.
    Hsu, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S91 - S91
  • [8] EQ-5D-5L Valuation for the Malaysian Population
    Asrul Akmal Shafie
    Annushiah Vasan Thakumar
    Ching Jou Lim
    Nan Luo
    Kim Rand-Hendriksen
    Faridah Aryani Md Yusof
    [J]. PharmacoEconomics, 2019, 37 : 715 - 725
  • [9] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558
  • [10] The EQ-5D-5L valuation study in Korea
    Kim, Seon-Ha
    Ahn, Jeonghoon
    Ock, Minsu
    Shin, Sangjin
    Park, Jooyeon
    Luo, Nan
    Jo, Min-Woo
    [J]. QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1845 - 1852